These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18865189)

  • 1. Relative experimental coronary vasodilator potencies and toxicities of papaverine, theophylline, and a papaverine-theophylline molecular association compound.
    WINDER CV; KAISER ME
    J Pharmacol Exp Ther; 1948 May; 93(1):86-92. PubMed ID: 18865189
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative experimental coronary vasodilator potencies of papaverine and its ethyl analogue, ethaverine (diquinol, perparin).
    WINDER CV; THOMAS RW; KAMM O
    J Pharmacol Exp Ther; 1950 Dec; 100(4:1):482-8. PubMed ID: 14804286
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of vasodilator agents on the development of collateral circulation in the myocardium following occlusion of the coronary artery].
    Sapozhkov AV
    Farmakol Toksikol; 1972; 35(3):297-9. PubMed ID: 5047294
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vasodilator agents in the therapy of pulmonary tuberculosis].
    VOTIN L
    Tuberkulozis; 1962 Nov; 15():335-7. PubMed ID: 13997982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Coronary dilators].
    Ilic-Vukotić M
    Med Arh; 1972; 26(2):81-4. PubMed ID: 4402269
    [No Abstract]   [Full Text] [Related]  

  • 6. [PHARMACOLOGY OF CORONARY VASODILATOR AGENTS].
    HASHIMOTO T
    Sogo Rinsho; 1964 Mar; 13():445-51. PubMed ID: 14140831
    [No Abstract]   [Full Text] [Related]  

  • 7. CURRENT THERAPEUTIC CONCEPTS OF CEREBRAL AND MYOCARDIAL VASCULAR DISEASE.
    FAZEKAS JF; ALMAN RW; TICKTIN HE; EHRMANTRAUT WR; SAVARESE CJ
    Angiology; 1964 Feb; 15():63-9. PubMed ID: 14118543
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of a new coronary vasodilator, theophylline-propane-sulfonate of papaverine].
    Vacheron A
    Sem Ther; 1968 Feb; 44(2):83-5. PubMed ID: 5744010
    [No Abstract]   [Full Text] [Related]  

  • 9. [Coronary drugs].
    de Lostalot J; Quilichini R
    Bord Med; 1972 Feb; 5(4):343-54. PubMed ID: 4402981
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of coronary vasodilator papaverine on heterologously-expressed HERG currents in Xenopus oocytes.
    Kim CS; Lee N; Son SJ; Lee KS; Kim HS; Kwak YG; Chae SW; Lee SD; Jeon BH; Park JB
    Acta Pharmacol Sin; 2007 Apr; 28(4):503-10. PubMed ID: 17376289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [INVERSION OF THE CORONARY DILATOR EFFECT OF SOME DRUGS BY ERGOTAMINE TARTRATE].
    ESPLUGUES J; BRUGGER A; HUESO E; SOTO L
    Rev Esp Fisiol; 1963 Dec; 19():155-62. PubMed ID: 14165287
    [No Abstract]   [Full Text] [Related]  

  • 12. Papaverine analogs. VI. Relationship between chemical structure and coronary vasodilator action.
    HANNA C; SHUTT JH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1953; 220(1-2):43-51. PubMed ID: 13132927
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasodilator action of KB-944, a new calcium antagonist.
    Morita T; Yoshino K; Kanazawa T; Ito K; Nose T
    Arzneimittelforschung; 1982; 32(9):1037-42. PubMed ID: 6890822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of action of papaverine on isolated coronary vessels].
    Kukovetz WR; Juan H; Pöch G
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):262-3. PubMed ID: 4310612
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the biological evaluation of coronary dilator agents].
    KHADZHAI IaI; CHERKASOVA IN
    Farmakol Toksikol; 1962; 25():573-8. PubMed ID: 14032230
    [No Abstract]   [Full Text] [Related]  

  • 16. [Measurement of coronary flow reserve using adenosine 5'-triphosphate in dogs].
    Kohno H; Yamada H; Azuma A; Kondo M; Yagi T; Kawata K; Tatsukawa H; Sugihara H; Nakagawa M
    J Cardiol; 1998 Jul; 32(1):1-8. PubMed ID: 9739511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symposium--coronary hemodynamic response to autonomic drugs and coronary vasodilators. 4. Coronary vasodilation produced by prostaglandin El (PGE1), dipyridamole, MG-345, acetylcholine, papaverine and sodium nitrite in the dog].
    Abiko Y; Minamidate A
    Nihon Yakurigaku Zasshi; 1970 Jul; 66(4):95. PubMed ID: 5531435
    [No Abstract]   [Full Text] [Related]  

  • 18. [Is adenosine the mediator for the regulation of the coronary circulation and for the effect of coronarodilators? Review].
    Meisel M; Meisel P
    Pharmazie; 1974 Sep; 29(9):361-8. PubMed ID: 4213610
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of coronary vasodilator on cyclic nucleotides. The concentrations of cyclic AMP and cyclic GMP in canine coronary artery and left ventricular muscle following the administration of various coronary vasodilators.
    Kobayashi A; Ogawa K
    Jpn Circ J; 1979 Dec; 43 Suppl 1():6-8, 46-54. PubMed ID: 230369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic actions of coronary vasodilator agents papaverine, dioxyline and verapamil.
    Hanna C; Schmid JR
    Arch Int Pharmacodyn Ther; 1970 Jun; 185(2):228-33. PubMed ID: 5473785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.